Daewoo Engineering & Construction Co. will develop wearable robots that can be worn by construction workers that could help prevent musculoskeletal disorders and maintain productivity.
The wearable robots consist of a waist support robot and a walking assistance robot. It will have sensors that will gather and analyze information about the workers' posture, weight, and working practices.
If their safety and efficacy are proven, Daewoo E&C will increase the supply of these robots to other industrial areas.
The company was selected in a contest held by the Korea Institute for Robot Industry Advancement to work in cooperation with local robotics startup Wirobotics and the Korea Orthopedics and Rehabilitation Center to develop and demonstrate smart work care services using wearable robot solutions.
The three parties, including Daewoo E&C, proposed the wearable robot and smart work care services concerning construction workers’ musculoskeletal issues and sustainable productivity.


Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure 



